1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor

New to insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development.

The first chapter of this report discusses microarray-based cytogenetics and how it compares to karyotyping. Karyotyping is often the standard method used to detect chromosomal aneuploidies, but with microarray-based procedures even more aneuploidies can be detected with the same efficacy. Either method can be used in sync with noninvasive procedures that show positive screening results for aneuploidies, but microarray analysis may be more useful for copy number variations that often go undetected with karyotyping.

Highlighting noninvasive methods, several companies have come out with novel technologies that allow them to analyze fetal DNA without risk of injury to the mother or fetus. Amniocentesis and chorionic villus sampling are common methods used to analyze fetal DNA for aneuploidies but at the risk of miscarriage and infection. With noninvasive procedures, screening can be done for common aneuploidies and further analysis can be done on women with only positive results. This not only decreases the amount of unnecessary invasive testing but also the amount of unnecessary stress levels of many expecting mothers. Companies participating in this section include:
• Sequenom
• Verinata Health
• Ariosa Diagnostics
• Natera
• Silicon Biosystems

Other areas discussed in this report include preeclampsia and preterm labor. Preeclampsia is a common condition in women and often isn’t detected until later in pregnancy. It can lead to preterm labor, which may be fatal for both the fetus and the mother. So far, a test to screen for the likelihood of preeclampsia does not exist. Detecting the risk of preeclampsia early in pregnancy can allow the expecting mother to take necessary action to avoid preterm labor at all costs, decreasing any complications that may severely affect the fetus including death. Companies highlighted in this section include:
• Metabolomic Diagnostics
• NX PharmaGen

In addition to covering several aspects of prenatal diagnostics, this report also includes specifications of particular instruments, exclusive interviews with CEOs, CSOs, and Vice Presidents of the participating companies. Specific areas of focus include company goals, customer feedback, challenges encountered, competitive advantage, platform pricing, and future endeavors. A survey capturing the demographics of the prenatal industry is presented at the end of the report, specifically highlighting organizational background, areas of research, challenges encountered, and applications in development.
Also included is a directory of companies that were and were not interviewed for this report.

Table Of Contents

Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
Executive Summary

Part I: Prenatal Applications

CHAPTER 1: Invasive Testing
Karyotyping
Microarray analysis

CHAPTER 2: Noninvasive Testing
Sequence-based cell-free DNA testing
Fetal cell isolation

Part II: Noninvasive Prenatal Applications

CHAPTER 3: Sequenom
Company background
Areas of Research
MaterniT21â„¢ PLUS
MaterniT21 PLUS validation
Competitive advantage
Future endeavors
Interview with William Welch; Dirk van den Boom; and Allan Bombard
• Company background
• Technologies in development
• SEQureDx platform
• MaterniT21 platform
• Validation techniques
• Areas of improvement
• Competitive advantage
• Customer feedback
• Future endeavors

CHAPTER 4: Verinata Health
Company background
The verifi® prenatal test
Challenges encountered
Clinical validation and reimbursement
Customer feedback
Interview with Richard Rava
• Company background
• verifi® prenatal test
• Challenges encountered
• Competitive advantage

CHAPTER 5: Ariosa Diagnostics
Company background
Harmony Prenatal Test
Competitive advantage
Future endeavors
Interview with Tom Musci
• Company background
• Harmony Test
• Competitive advantage
• Future endeavors

CHAPTER 6: Natera
Company background
Panorama
Platform improvements
Validation
Challenges encountered
Competitive advantage
Future endeavors
Interview with Solomon Moshkevich
• Company background
• Panorama
• Platform improvements
• Validation
• Challenges encountered
• Customer feedback
• Competitive advantage
• Future endeavors

CHAPTER 7: Silicon Biosystems
Company background
DEPArray System
Challenges encountered
Competitive advantage
Future endeavors
Interview with Robert Proulx
• Company background
• DEPArray Platform
• Challenges encountered
• Customer feedback
• Future endeavors

CHAPTER 8: Noninvasive Screening Test Specifications

Part III: Prenatal Complications

CHAPTER 9: Prenatal Complications
Preeclampsia
Preterm labor

CHAPTER 10: Metabolomic Diagnostics
Company background
Preeclampsia screening test
Competitive advantage
Future endeavors
Interview with Charles Garvey
• Company background
• Areas of research
• Competitive advantage
• Future endeavors

CHAPTER 11: NX PharmaGen
Company background
NeXosome platform
Competitive advantage
Future endeavors
Interview questions with Dr. Alan Ezrin and Brian Brohman
• Company background
• Preterm labor assays
• Challenges encountered
• Competitive advantage
• Future endeavors

Part IV: Demographic Survey

CHAPTER 12: Survey Results
Survey demographics
Areas of research
Challenges encountered
Applications being used for prenatal diagnostics
Competitive strategies

Part V: Company Directory: A list of companies working in Prenatal Diagnostics

References
About Cambridge Healthtech Institute



Figures:

Figure 12.1: Survey demographics
Figure 12.2: Screening vs. testing
Figure 12.3: Specific areas of research
Figure 12.4: Challenges encountered
Figure 12.5: Preferred applications of use
Figure 12.6: Competitive strategies



Tables:

Table 3.1: MaterniT21 PLUS aneuploidy performance
Table 3.2: MaterniT21 PLUS
Table 4.1: verifi prenatal test performance for aneuploidies
Table 4.2: verifi prenatal test performance for sex chromosomes
Table 4.3: verifi prenatal test
Table 5.1 Harmony Test
Table 6.1: Panorama Test
Table 7.1: DEPArray System
Table 8.1: Noninvasive screening test specifications

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Polymerase Chain Reaction (PCR) Technologies and Global Markets

Polymerase Chain Reaction (PCR) Technologies and Global Markets

  • $ 6650
  • Industry report
  • August 2016
  • by BCC Research

This BCC Research report explores the current and future PCR product market, which includes instruments, reagents and consumables, and software and services. It also looks at innovations, market drivers ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.